Bladder cancer decisions — 2023

The Veteran's bladder cancer residuals are rated at 60 percent, but his skin disability is rated at 10 percent.,The Board has remanded the issue of service connection for right ear hearing loss.

The Board has remanded the Veteran's claim for service connection for bladder cancer due to exposure to diesel fuel, as there is insufficient evidence regarding the etiology of his condition. The case will be reviewed by a VA examiner to provide an opinion on whether the Veteran's bladder cancer is related to his military service.

The Veteran's appeals for increased ratings were denied. The bladder cancer residuals are rated at the maximum schedular disability rating of 60 percent, and the psychiatric disorder is currently rated at 30 percent.

The Board has decided to remand the case due to new evidence and a need for a VA examination regarding the Veteran's bladder cancer.

The Board has granted the Veteran's claim for service connection for bladder cancer, finding that his current condition is at least as likely as not related to his in-service exposure to herbicide agents. The decision resolves the benefit of doubt in favor of the Veteran.

The claim for service connection for bladder cancer has been dismissed because the appellant died during the appeal process.

The Veteran's appeal to reduce his bladder cancer rating from 100% to 40% effective November 1, 2023 has been dismissed due to the appellant's withdrawal of the appeal.

The Board denied service connection for diabetes mellitus, bladder cancer, and prostate cancer prior to August 10, 2022 on the basis of direct herbicide exposure. The evidence did not support such a finding.

The Veteran's death is due to his service-connected bladder cancer, which was caused by his in-service exposure to herbicide agents like Agent Orange. As a result, the Board has granted entitlement to service connection for the cause of the Veteran's death.

The Board has remanded the claims of service connection for throat cancer, bladder cancer, and skin cancer of the face and chest due to a duty to assist error. A VA examination is needed to assess whether these cancers are related to exposure to mustard gas during service.

The Board has granted service connection for deep vein thrombosis as secondary to the Veteran's service-connected bladder cancer.

The Board has denied service connection for bladder cancer, heart condition, hypothyroidism, migratory inflammatory arthritis of the elbows, wrists, fingers, thumbs, hips, and knees, as well as left and right shoulder conditions due to lack of evidence linking these conditions to active service.,Service connection was not granted because there is no medical evidence showing that any of the claimed conditions were incurred or aggravated during military service.

Your claim for service connection for bladder cancer has been fully granted, effective October 24, 2018. The appeal is dismissed as the issue is no longer pending.

The Veteran's TDIU is denied as he did not meet the schedular requirements for a TDIU prior to January 1, 2021. The effective date of the award of SMC based on statutory housebound criteria is granted.,The Veteran does not have any service-connected conditions that qualify under the PACT Act, Agent Orange, Camp Lejeune, or radiation exposure.

The Veteran's TDIU claim is granted with an effective date of October 26, 2016. The period from October 26, 2016 through December 31, 2016 is excluded due to the mootness of the TDIU during this period.

The Board has remanded the claims for sigmoid colon cancer and bladder cancer due to insufficient reasons or bases provided in the previous decisions. The Appellant requested additional evidence, which was submitted and considered.

The Board has remanded the claim for service connection for bladder pheochromocytoma and/or bladder cancer due to inadequate VA examinations, lack of clarity in medical evidence, and need for a new examination.

The Veteran's claim for a compensable rating for bladder cancer from January 1, 2017 to May 5, 2017 is denied as there is no evidence of current bladder cancer or its residuals during this period.

The Veteran's service-connected disabilities, including unspecified trauma and stressor related disorder with a depressive disorder, residuals of bladder cancer, bilateral hearing loss, and tinnitus, have rendered him unemployable since October 21, 2019. The Board has granted TDIU effective from that date.

The Board denied the Veteran's claims for an initial rating in excess of 10 percent for bladder cancer residuals and continuance of a 100 percent disability rating for service-connected bladder cancer status post transurethral resection of the bladder tumor, finding that the evidence did not support these ratings from June 22, 2023.